• Loading stock data...
PublicWire | Emerging Market Stock News
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
No Result
View All Result
PublicWire
No Result
View All Result

Home » Medical » Regeneron to buy back $5 billion shares from Sanofi

Regeneron to buy back $5 billion shares from Sanofi

Enzo Mayor by Enzo Mayor
May 25, 2020
in Medical
2 min read
37
0
Regeneron buy back shares from Sanofi

Regeneron Pharmaceuticals announced on Monday that it would buy back $5 billion worth of its shares from Sanofi, a French multinational pharmaceutical company. The announcement goes in line with the commencement of Regeneron’s underwritten public secondary offering of its common stock in which Sanofi “intends to exit its investment.”

Sanofi owns 23.2 million Regeneron shares and plans to sell 12.8 million shares in the public offering. The company expects to grant underwriters a 30-day option to purchase an additional 10% of the shares offered in the base offering, says the press release.

Regeneron’s $5 billion worth of repurchase of its common stock from Sanofi will be funded by a $3.5 billion of cash and $1.5 billion of financing.

“Following the offering and Regeneron’s $5 billion share repurchase, and assuming that the underwriters exercise their option to purchase additional shares in full, Sanofi will have disposed of all of its shares, other than 400,000 shares it intends to retain.”

The offering and repurchase by Renegeron will not have any form of impact on the ongoing collaboration between the two drugmakers, which was dated back to 2003.

Paul Hudson, the Chief Executive Officer of Sanofi, notes that the offering aims to execute the company’s strategy to drive “innovation and growth.”

“Sanofi remains committed to continuing our collaboration with Regeneron, which remains an integral part of our overall strategy,” Hudson adds.

The offering will co-occur in the United States and internationally through underwriters led by BofA Securities and Goldman Sachs as joint book-running managers.

Enzo Mayor

Enzo Mayor

I'm a management degree holder, currently working for a family business. I find myself always indulging on new interests -- from fitness, coffee, writing, travel, and marketing. But by the end of the day, I'm just a guy in a perpetual pursuit to find his balance.

Related Posts

A report reveals that China is deliberately faking the number of COVID-19 cases and deaths.
General

China is underreporting COVID-19 cases, U.S. intelligence community says

April 1, 2020
152
Around the world, the total number of confirmed coronavirus infection went beyond 600,000, with 28,964 fatalities as of the latest report.
Medical

17% of all confirmed COVID-19 cases in the world comes from the US

March 28, 2020
139
President Donald Trump signed a $2 trillion coronavirus relief bill on Friday
General

Trump signs $2 trillion coronavirus relief

March 28, 2020
121
General Motors and Ventec Life Systems are partnering to convert the GM Kokomo, Indiana ERC building for the production of Ventec ventilators in response to the COVID-19 pandemic.
General

GM announces the start of production of critical-care ventilators shortly after Trump’s tweets against CEO

March 27, 2020
135
Rep. Thomas Massie, R-Ky., tried to force a full yes or no vote on the measure, which could have delayed its passage by hours.
Finance

$2 trillion coronavirus stimulus package passed by the House amid efforts to delay voting by Massie

March 27, 2020
123
The number of COVID-19 infections climbed to reach 566,373, with more than 25,427 fatalities around the world.
Medical

COVID-19 infects more than half million people; WHO considers ‘airborne precautions’ for medical staff

March 27, 2020
140
Currently Playing

Subscribe To Our Newsletter

Ad

PublicWire | Emerging Market Stock News 24/7 | Investor Relations US Stock Market

© Copyright 2020 PublicWire.com

Navigate Site

  • About
  • #96576 (no title)
  • Disclaimer
  • Watch LIVE
  • Privacy Policy
  • Terms and Services
  • Contributors

Follow Us

No Result
View All Result
  • LIVE Investor News Channel
  • Cannabis
  • Energy
  • Finance
  • General
  • Medical
  • Podcasts
  • Retail
  • Technology
  • #370 (no title)

© Copyright 2020 PublicWire.com

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Public Wire Logo

Hello please subscribe to our newsletter to get up to date news weekly!

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.